Exp Clin Endocrinol Diabetes 2017; 125(03): 147-150
DOI: 10.1055/s-0042-101791
Article
© Georg Thieme Verlag KG Stuttgart · New York

Correlation between Bethatrophin and 25(OH)D Concentrations in a Group of Subjects With Normal and Impaired Glucose Metabolism

H. Turkon
1   Department of Medical Biochemistry, Çanakkale Onsekiz Mart University, Faculty of Medicine, Çanakkale, Turkey
,
H. Yalcın
2   Department of Clinical Biochemistry, Tepecik Teaching and Research Hospital, Izmir, Turkey
,
B. Toprak
3   Department of Clinical Biochemistry, Silopi State Hospital, Sırnak, Turkey
,
M. Demirpençe
4   Department of Endocrinology, Tepecik Teaching and Research Hospital Izmir, Turkey
,
H.Y. Yaşar
4   Department of Endocrinology, Tepecik Teaching and Research Hospital Izmir, Turkey
,
A. Colak
2   Department of Clinical Biochemistry, Tepecik Teaching and Research Hospital, Izmir, Turkey
› Author Affiliations
Further Information

Publication History

received 12 January 2016
first decision 12 January 2016

accepted 27 January 2016

Publication Date:
24 February 2016 (online)

Abstract

Aim: Inducing beta cell replication is a potential therapeutic approach for the treatment of diabetes mellitus. Recently betatrophin was suggested as a novel stimulator of beta cell proliferation in mice but its role in humans remains to be established. We aimed to investigate betatrophin concentration and its association with metabolic parameters in a group of individuals with normal glucose tolerance, pre-diabetes and diabetes mellitus who had not been previously treated.

Methods: A total of 72 subjects were recruited for this cross sectional study: 23 subjects with normal glucose tolerance (NGT), 22 subjects with prediabetes, and 27 subjects with diabetes mellitus (DM). Circulating betatrophin concentration, 75 g oral glucose tolerance test, fasting insulin, glycosylated hemoglobin, 25hydroxy vitamin D and HOMA IR were measured.

Results: The difference in betatrophin values did not reach statistical significance between the 3 groups [NGT:206 (176–297)pg/mL, Prediabetes:232 (181–254)pg/mL, DM:245 (205–526)pg/mL, p=0.078]. Betatrophin was negatively significantly correlated with BMI and positively significantly correlated with 25(OH)vitD (p=0.043 and p=0.001 respectively). Multivariate linear regression showed that 25(OH) vitD (β=0.440 p=0.001) and fasting glucose (β=0.003 p=0.038) were variables associated with betatrophin concentration (R2=0.251).

Conclusions: In a group of subjects ranging from those with normal glucose tolerance to newly diagnosed diabetes, we found that 25(OH)D and fasting glucose were factors associated with serum betatrophin concentration.

 
  • References

  • 1 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl. 01) S81-S90
  • 2 Araújo TG, Oliveira AG, Saad MJ. Insulin-resistance-associated compensatory mechanisms of pancreatic Beta cells: a current opinion. Front Endocrinol (Lausanne) 2013; 4: 146
  • 3 Weir GC, Bonner-Weir S. Islet cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci 2013; 1281: 92-105
  • 4 Rieck S, White P, Schug J et al. The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol 2009; 23: 1702-1712
  • 5 Alonso LC, Yokoe T, Zhang P et al. Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 2007; 56: 1792-1801
  • 6 Pick A, Clark J, Kubstrub C et al. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998; 47: 358-364
  • 7 Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 2013; 153: 747-758
  • 8 Tseng YH, Yeh YH, Chen WJ et al. Emerging regulation and function of betatrophin. Int J Mol Sci 2014; 15: 23640-23657
  • 9 Jiao Y, Le Lay J, Yu M et al. Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting. Diabetes 2014; 63: 1283-1288
  • 10 Hu H, Sun W, Yu S. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014; 37: 2718-2722
  • 11 Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014; 2014: 323407
  • 12 Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2014; 57: 50-53
  • 13 Gómez-Ambrosi J, Pascual E, Catalán V et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 2014; 99: E2004-E2009
  • 14 Fu Z, Berhane F, Fite A et al. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 2014; 4: 5013
  • 15 Fu Z, Abou-Samra AB, Zhang R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 2014; 57: 2232-2234
  • 16 Lim S, Kim MJ, Choi SH et al. Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr 2013; 97: 524-530
  • 17 Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 2013; 59: 381-391
  • 18 Kayaniyil S, Retnakaran R, Harris SB et al. Prospective associations of vitamin d with β-cell function and glycemia the prospective metabolism and islet cell evaluation (PROMISE) cohort study. Diabetes 2011; 60: 2947-2953
  • 19 Mitri J, Dawson-Hughes B, Hu FB et al. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-494
  • 20 Kampmann U, Mosekilde L, Juhl C et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial. Metabolism 2014; 63: 1115-1124
  • 21 von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555
  • 22 Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351385
  • 23 Pittas AG, Lau J, Hu FB et al. The role of vitamin D and calcium in type 2 diabetes. A systematic Review and meta-Analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029
  • 24 Cox AR, Lam CJ, Bonnyman CW et al. Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice. Diabetologia 2015; 58: 1523-1531
  • 25 Chen J, Chen S, Huang P et al. In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia 2015; 58: 1036-1044
  • 26 Gusarova V, Alexa CA, Na E et al. ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 2014; 159: 691-696
  • 27 Yi P, Park JS, Melton DA. Perspectives on the activities of ANGPTL8/betatrophin. Cell 2014; 159: 467-468